APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prescription Gastrointestinal Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prescription Gastrointestinal Drugs Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchPrescription Gastrointestinal Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Gastrointestinal Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Prescription Gastrointestinal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Gastrointestinal Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Gastrointestinal Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Prescription Gastrointestinal Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prescription Gastrointestinal Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prescription Gastrointestinal Drugs market include Eisai, Merck, GlaxoSmithKline, AstraZeneca, Salix Pharmaceuticals and Axcan Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prescription Gastrointestinal Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prescription Gastrointestinal Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prescription Gastrointestinal Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prescription Gastrointestinal Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Prescription Gastrointestinal Drugs Segment by Company

Eisai

Merck

GlaxoSmithKline

AstraZeneca

Salix Pharmaceuticals

Axcan Pharmaceuticals

Prescription Gastrointestinal Drugs Segment by Type

Oral

Topical

Prescription Gastrointestinal Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Prescription Gastrointestinal Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prescription Gastrointestinal Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Prescription Gastrointestinal Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prescription Gastrointestinal Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Prescription Gastrointestinal Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Gastrointestinal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Gastrointestinal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Gastrointestinal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prescription Gastrointestinal Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prescription Gastrointestinal Drugs industry.

Chapter 3: Detailed analysis of Prescription Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Prescription Gastrointestinal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Prescription Gastrointestinal Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prescription Gastrointestinal Drugs Industry Trends Table 2. Prescription Gastrointestinal Drugs Industry Drivers Table 3. Prescription Gastrointestinal Drugs Industry Opportunities and Challenges Table 4. Prescription Gastrointestinal Drugs Industry Restraints Table 5. Global Prescription Gastrointestinal Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prescription Gastrointestinal Drugs Revenue Share by Company (2021-2026) Table 7. Global Prescription Gastrointestinal Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Prescription Gastrointestinal Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Prescription Gastrointestinal Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Prescription Gastrointestinal Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Prescription Gastrointestinal Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Prescription Gastrointestinal Drugs Company, Product Type & Application Table 13. Global Prescription Gastrointestinal Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Prescription Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Table 18. Significant Companies of Topical Table 19. Global Prescription Gastrointestinal Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Prescription Gastrointestinal Drugs Sales Volume by Type (2021-2026) & (k units) Table 21. Global Prescription Gastrointestinal Drugs Sales Volume by Type (2027-2032) & (k units) Table 22. Global Prescription Gastrointestinal Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Prescription Gastrointestinal Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Prescription Gastrointestinal Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Prescription Gastrointestinal Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Prescription Gastrointestinal Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Prescription Gastrointestinal Drugs Sales Value Share by Type (2021-2026) Table 28. Global Prescription Gastrointestinal Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Online Pharmacies Table 30. Significant Companies of Hospital Pharmacies Table 31. Significant Companies of Retail Pharmacies Table 32. Global Prescription Gastrointestinal Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Prescription Gastrointestinal Drugs Sales Volume by Application (2021-2026) & (k units) Table 34. Global Prescription Gastrointestinal Drugs Sales Volume by Application (2027-2032) & (k units) Table 35. Global Prescription Gastrointestinal Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Prescription Gastrointestinal Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Prescription Gastrointestinal Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Prescription Gastrointestinal Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Prescription Gastrointestinal Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Prescription Gastrointestinal Drugs Sales Value Share by Application (2021-2026) Table 41. Global Prescription Gastrointestinal Drugs Sales Value Share by Application (2027-2032) Table 42. Global Prescription Gastrointestinal Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Prescription Gastrointestinal Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2021-2026) Table 45. Global Prescription Gastrointestinal Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2027-2032) Table 47. Global Prescription Gastrointestinal Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Prescription Gastrointestinal Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Prescription Gastrointestinal Drugs Sales Value Share by Region (2021-2026) Table 50. Global Prescription Gastrointestinal Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Prescription Gastrointestinal Drugs Sales Value Share by Region (2027-2032) Table 52. Global Prescription Gastrointestinal Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Prescription Gastrointestinal Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Prescription Gastrointestinal Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Prescription Gastrointestinal Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Prescription Gastrointestinal Drugs Sales by Country (2021-2026) & (k units) Table 57. Global Prescription Gastrointestinal Drugs Sales Market Share by Country (2021-2026) Table 58. Global Prescription Gastrointestinal Drugs Sales by Country (2027-2032) & (k units) Table 59. Global Prescription Gastrointestinal Drugs Sales Market Share by Country (2027-2032) Table 60. Global Prescription Gastrointestinal Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Prescription Gastrointestinal Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Prescription Gastrointestinal Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Prescription Gastrointestinal Drugs Sales Value Market Share by Country (2027-2032) Table 64. Eisai Company Information Table 65. Eisai Business Overview Table 66. Eisai Prescription Gastrointestinal Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Eisai Prescription Gastrointestinal Drugs Product Portfolio Table 68. Eisai Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Prescription Gastrointestinal Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Merck Prescription Gastrointestinal Drugs Product Portfolio Table 73. Merck Recent Development Table 74. GlaxoSmithKline Company Information Table 75. GlaxoSmithKline Business Overview Table 76. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio Table 78. GlaxoSmithKline Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca Prescription Gastrointestinal Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio Table 83. AstraZeneca Recent Development Table 84. Salix Pharmaceuticals Company Information Table 85. Salix Pharmaceuticals Business Overview Table 86. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio Table 88. Salix Pharmaceuticals Recent Development Table 89. Axcan Pharmaceuticals Company Information Table 90. Axcan Pharmaceuticals Business Overview Table 91. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio Table 93. Axcan Pharmaceuticals Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Prescription Gastrointestinal Drugs Distributors List Table 97. Prescription Gastrointestinal Drugs Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Prescription Gastrointestinal Drugs Product Image Figure 2. Global Prescription Gastrointestinal Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Gastrointestinal Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Prescription Gastrointestinal Drugs Sales (2021-2032) & (k units) Figure 5. Global Prescription Gastrointestinal Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Prescription Gastrointestinal Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Image Figure 10. Topical Image Figure 11. Global Prescription Gastrointestinal Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Prescription Gastrointestinal Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Prescription Gastrointestinal Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Prescription Gastrointestinal Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Prescription Gastrointestinal Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Prescription Gastrointestinal Drugs Sales Value Share by Type (2021-2032) Figure 17. Online Pharmacies Image Figure 18. Hospital Pharmacies Image Figure 19. Retail Pharmacies Image Figure 20. Global Prescription Gastrointestinal Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Prescription Gastrointestinal Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Prescription Gastrointestinal Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Prescription Gastrointestinal Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Prescription Gastrointestinal Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Prescription Gastrointestinal Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Prescription Gastrointestinal Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Prescription Gastrointestinal Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Prescription Gastrointestinal Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Prescription Gastrointestinal Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Prescription Gastrointestinal Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Prescription Gastrointestinal Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Prescription Gastrointestinal Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Prescription Gastrointestinal Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Prescription Gastrointestinal Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Prescription Gastrointestinal Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Prescription Gastrointestinal Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Prescription Gastrointestinal Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Prescription Gastrointestinal Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Prescription Gastrointestinal Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Prescription Gastrointestinal Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Prescription Gastrointestinal Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Topical
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Eisai
  • Merck
  • GlaxoSmithKline
  • AstraZeneca
  • Salix Pharmaceuticals
  • Axcan Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prescription Gastrointestinal Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Prescription Gastrointestinal Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Prescription Gastrointestinal Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Prescription Gastrointestinal Drugs Market Dynamics
  1. 2.1 Prescription Gastrointestinal Drugs Industry Trends
  2. 2.2 Prescription Gastrointestinal Drugs Industry Drivers
  3. 2.3 Prescription Gastrointestinal Drugs Industry Opportunities and Challenges
  4. 2.4 Prescription Gastrointestinal Drugs Industry Restraints
3 Prescription Gastrointestinal Drugs Market by Company
  1. 3.1 Global Prescription Gastrointestinal Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Prescription Gastrointestinal Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Prescription Gastrointestinal Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Prescription Gastrointestinal Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Prescription Gastrointestinal Drugs Company Ranking (2024-2026)
  6. 3.6 Global Prescription Gastrointestinal Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Prescription Gastrointestinal Drugs Company Product Type and Application
  8. 3.8 Global Prescription Gastrointestinal Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Prescription Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Prescription Gastrointestinal Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Prescription Gastrointestinal Drugs Market by Type
  1. 4.1 Prescription Gastrointestinal Drugs Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Topical
  4. 4.2 Global Prescription Gastrointestinal Drugs Sales Volume by Type
  5. 4.2.1 Global Prescription Gastrointestinal Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Prescription Gastrointestinal Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Prescription Gastrointestinal Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Prescription Gastrointestinal Drugs Sales Value by Type
  9. 4.3.1 Global Prescription Gastrointestinal Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Prescription Gastrointestinal Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Prescription Gastrointestinal Drugs Sales Value Share by Type (2021-2032)
5 Prescription Gastrointestinal Drugs Market by Application
  1. 5.1 Prescription Gastrointestinal Drugs Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Prescription Gastrointestinal Drugs Sales Volume by Application
  6. 5.2.1 Global Prescription Gastrointestinal Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prescription Gastrointestinal Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Prescription Gastrointestinal Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Prescription Gastrointestinal Drugs Sales Value by Application
  10. 5.3.1 Global Prescription Gastrointestinal Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prescription Gastrointestinal Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Prescription Gastrointestinal Drugs Sales Value Share by Application (2021-2032)
6 Prescription Gastrointestinal Drugs Regional Sales and Value Analysis
  1. 6.1 Global Prescription Gastrointestinal Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prescription Gastrointestinal Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Prescription Gastrointestinal Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Prescription Gastrointestinal Drugs Sales by Region (2027-2032)
  5. 6.3 Global Prescription Gastrointestinal Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Prescription Gastrointestinal Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Prescription Gastrointestinal Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Prescription Gastrointestinal Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Prescription Gastrointestinal Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Prescription Gastrointestinal Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Prescription Gastrointestinal Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Prescription Gastrointestinal Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Prescription Gastrointestinal Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Prescription Gastrointestinal Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Prescription Gastrointestinal Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Prescription Gastrointestinal Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Prescription Gastrointestinal Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Prescription Gastrointestinal Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Prescription Gastrointestinal Drugs Sales Value Share by Country, 2025 VS 2032
7 Prescription Gastrointestinal Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Prescription Gastrointestinal Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prescription Gastrointestinal Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Prescription Gastrointestinal Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Prescription Gastrointestinal Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Prescription Gastrointestinal Drugs Sales by Country (2027-2032)
  6. 7.4 Global Prescription Gastrointestinal Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Prescription Gastrointestinal Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Prescription Gastrointestinal Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Prescription Gastrointestinal Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Prescription Gastrointestinal Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Prescription Gastrointestinal Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Prescription Gastrointestinal Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Prescription Gastrointestinal Drugs Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Prescription Gastrointestinal Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Prescription Gastrointestinal Drugs Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Prescription Gastrointestinal Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Salix Pharmaceuticals
  26. 8.5.1 Salix Pharmaceuticals Company Information
  27. 8.5.2 Salix Pharmaceuticals Business Overview
  28. 8.5.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
  30. 8.5.5 Salix Pharmaceuticals Recent Developments
  31. 8.6 Axcan Pharmaceuticals
  32. 8.6.1 Axcan Pharmaceuticals Company Information
  33. 8.6.2 Axcan Pharmaceuticals Business Overview
  34. 8.6.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
  36. 8.6.5 Axcan Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prescription Gastrointestinal Drugs Value Chain Analysis
  2. 9.1.1 Prescription Gastrointestinal Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prescription Gastrointestinal Drugs Sales Mode & Process
  6. 9.2 Prescription Gastrointestinal Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prescription Gastrointestinal Drugs Distributors
  9. 9.2.3 Prescription Gastrointestinal Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst